Meihua International Medical Technologies Co., Ltd. (MHUAF) stock
Close on Oct 19, 2026Market cap –P/E 0.4Yield –
Meihua International Medical Technologies Co., Ltd. saw revenue fall 36.2% to $61.79M over fiscal 2025. Operating income fell 42.1% to $8.28M, moving the operating margin from 14.8% to 13.4%. Free cash flow was $554.25K, down 96.2% from a year earlier.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- 0.4
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $61.79M
- Net income
- $6.78M
- EPS, diluted
- $18.04
- Free cash flow
- $554.25K
Trading
- Previous close
- $6.50
- Open
- $6.50
- Day's range
- $6.50 – $6.50
- Volume
- 0
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | MHUAF | S&P 500 | Difference | MHUAF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -7.1% | +0.6% | −7.8 pts | ||
| 3 months | -25.9% | +3.4% | −29.3 pts | ||
| Year to date | +217.1% | +13.3% | +203.8 pts | ||
| 1 year | -80.2% | +16.6% | −96.9 pts | ||
| 3 years | -96.4% | +86.4% | −182.8 pts | -66.9% | +23.1% |
Eight years at a glance
Fiscal years 2018 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Meihua International Medical Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Meihua International Medical Technologies
Surgical & Medical Instruments & Apparatus
Meihua International Medical Technologies Co., Ltd. is a provider and distributor of disposable medical devices. Operating primarily through Chinese subsidiaries, the company manufactures and sells Class I, Class II, and Class III disposable medical devices under its proprietary brands, while also distributing products sourced from third-party manufacturers. Its product portfolio includes non-bottled items such as brushes and identification bracelets, as well as polyethylene bottled goods like eye drop bottles and tablet containers. In addition, the organization maintains operations dedicated to medical technology trading, import-export facilitation, and software-as-a-service development. Its customer base consists of domestic and overseas clients.
Company profile, executives and historyMeihua International Medical Technologies stock: common questions
What is Meihua International Medical Technologies's stock price?
MHUAF closed at $6.50 on Oct 19, 2026, up 0.00% on the day.
What is MHUAF's P/E ratio?
MHUAF trades at 0.4 times earnings, based on diluted earnings per share of $18.04 over fiscal 2025.
How much revenue does Meihua International Medical Technologies make?
Meihua International Medical Technologies reported revenue of $61.79M for fiscal 2025, down 36.2% from a year earlier.
Does Meihua International Medical Technologies pay a dividend?
No. Meihua International Medical Technologies has not paid a cash dividend over the last twelve months.
How has MHUAF stock performed over the past year?
Including dividends, MHUAF returned -80.2% over the past year, against +16.6% for the S&P 500.
Who are Meihua International Medical Technologies's competitors?
Companies most similar to Meihua International Medical Technologies by business, industry and size include BDMD, KRMD, APYX, RVP, LNSR.
See a number that looks wrong?